Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria
Clinical trial NCT00519467 · COMPLETED
Trial details
- NCT number
- NCT00519467
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2005-02-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.